Comparing bone mineral density in rheumatoid arthritis and psoriatic arthritis
Authors
Abstract:
Background: Changes in patients’ bone mineral density (BMD) is one of the problems in patients with rheumatoid arthritis, which can be due to the use of corticosteroid drugs to reduce patients' symptoms or due to the aging process in patients. In this study, we decided to compare BMD in patients with psoriatic arthritis and rheumatoid arthritis. Methods: This study as a cross-sectional descriptive-analytical study was performed to evaluate BMD in patients with psoriatic arthritis (n = 59) and rheumatoid arthritis (n = 41) that referred to Rasoul Akram Hospital in Tehran between 2016 and 2020. All patients were assessed by bone density scan (dual-energy X-ray absorptiometry or DEXA scan) to determine T score at the two spine and femur sites. Results: In the rheumatoid arthritis and psoriatic arthritis groups, the mean spine T score was -1.11±0.18 and -1.38±0.48, respectively, which did not show a significant difference between the two groups (p = 0.556). Similarly, in the two groups with rheumatoid arthritis and psoriatic arthritis, the mean femur T score was -1.36±0.17 and -1.78±0.61, respectively, which did not show a significant difference between the two groups (p = 0.451). Considering the underlying parameters including age, sex and duration of the disease, the lack of differences in the values of spine and femur T scores between the two groups was still evident. Conclusion: The change in BMD was equal in both rheumatoid arthritis and psoriatic arthritis that is not affected by gender, age or duration of disease.
similar resources
Assessing periarticular bone mineral density in patients with early psoriatic arthritis or rheumatoid arthritis.
BACKGROUND Periarticular osteoporosis is an early finding in the hands of patients with rheumatoid arthritis (RA), due to release of bone resorbing cytokines from the inflamed synovium. There has been disagreement as to whether periarticular bone loss occurs in psoriatic arthritis (PsA). Bone mineral density (BMD) can now be measured accurately using dual energy x ray absorptiometry (DEXA). Rec...
full textBone mineral density loss in postmenopausal onset rheumatoid arthritis is not greater than premenopausal onset disease
Background: Postmenopausal onset rheumatoid arthritis (post-RA) is expected to have greater bone mineral density (BMD) loss than premenopauasal onset (pre-RA) due to estrogen deficiency and aging. This study aimed to compare the BMD status of the two RA groups with age-matched non-RA controls. Methods: The patients with RA on follow-up examination were stratified according to age of onset. ...
full textBone mineral density loss in postmenopausal onset rheumatoid arthritis is not greater than premenopausal onset disease
Abstract Background: Postmenopausal onset rheumatoid arthritis (post-RA) is expected to have greater bone mineral density (BMD) loss than premenopauasal onset (pre-RA) due to estrogen deficiency and aging. This study aimed to compare the BMD status of the two RA groups with age-matched non-RA controls. Methods: The patients with RA on follow-up examination were stratified according to age...
full textBone mineral density changes during treatment of rheumatoid arthritis with disease-modifying-anti-rheumatic drugs
Background: Bone mineral density (BMD) changes during the course of rheumatoid arthritis (RA). The present study was designed to investigate the status of BMD in patients with RA treated with anti-rheumatic drugs. Methods: BMD at the femoral neck (FN-BMD) and lumbar spine (LS-BMD) were measured by dual energy x-ray absorptiometry (DXA) method using Norland densitometer. Disease activity (DA) wa...
full textBone mineral density in patients with Juvenile Rheumatoid Arthritis
Results There were 37 patients with JRA (33 girls and 4 boys, with a mean age of 12.31 ± 3.29 years) and 20 healthy controls (matched for age and sex ratio with JRA patients) were consecutively recruited in this study between 2005 and 2007. BMD of the calcaneus in the patients with JRA was significantly lower than that in healthy controls ((0.71 ± 0.13) g/cm^2 vs (0.97 ± 0.18) g/cm^2, P < 0.05)...
full textBone mineral density in nonsteroid treated early rheumatoid arthritis.
OBJECTIVES To determine whether significant reduction in bone mass is detectable in early disease in patients with rheumatoid arthritis (RA) and to examine the possible influences of disease activity and physical disability on bone mineral density (BMD) of the lumbar spine (LS) and femoral neck (FN). METHODS LS and FN BMD values were measured and Z scores determined in a cross-sectional study...
full textMy Resources
Journal title
volume 25 issue 2
pages 0- 0
publication date 2022-05
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023